Canadian researchers looked at the safety of short-term use in patients with hypertension, heart failure, or chronic kidney disease.
Inclusive Trials, Informed Treatments: Prioritizing Diversity in Clinical Research
Emerging Agents in the Treatment of Rheumatic Diseases
Prolonged Medical Fasting May Benefit Pain Symptoms in Fibromyalgia
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
MRI Treat-to-Target Strategy Fails to Help RA Patients Reach Remission
FDA Grants Nipocalimab Fast Track Designation for Rare Fetal Disease, with Katie Abouzahr, MD